2Josep M, Jordi Bruix. Novel carcinoma in 2008[J].Journal of Hepatology,2008,48:S20-S37.
3De vel opment of Sor afenib and Other Mol ecula r l y Targe ted Agen ts i n Hep atocel lul arCarcinoma[J]. Cancer,2008,112:250–9.
4Lim SO, Kim H, Jung G. p53 degradation of snail protein in hepatocellular carcinoma[J]. FEBSLett. 2010,584(11):2231-6.
5Zeng zC,Tang ZY.A compar ison of chemoembol izat ion combinat ion wi th and wi thoutradiotherapy for unresectable hepatocellular carcinoma[J].Cancer J,2004,10:307-316.
6Wulf J,Guckenberger M, Haedinger U,et a1. Acta Oncot,2006,45(7):838--47.
7Nag S, DeHaan M, Scruggs G.et a1. Int J Radiat Oncol Biol phys,2006,64(3):736-44.
8Yasui H, Ogura A, Asanuma T, Matsuda A, Br J Cancer 2008, 99:1442-1452.
9Matsui O, Miyayama S, et al, Interventional oncology:new TACE using iodized oil for HCC:rationale, technique and outcome[J].J Hepatobiliary Pancreat Sci,2010,17(4):407-9.
1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量：214
